Astellas Pharma US, Inc.
Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications
Published in Drug Week, August 28th, 2009
Astellas Pharma US, Inc. ("Astellas") announced an update regarding the status of the request for emergency relief and preliminary injunction from the U.S. Food and Drug Administration's (FDA) decision regarding its Citizen Petition. The company's requests have been denied by the U.S. District Court in Washington, D.C. The company is disappointed in the court's decision and is currently evaluating its next course of action.
The Citizen Petition requested that the FDA ensure the safe and effective use of immunosuppressants (also called anti-rejection medications) used to prevent rejection in organ transplant patients. The petition sought additional measures from the FDA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2009-08-28)
More Articles from Drug Week
- Alcoholism
A synthetic derivative of the kudzu vine can reduce drinking and prevent relapse - American Association for Cancer Research
Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients - American Dietetic Association
ADA publishes practice guidelines for nutrition care for patients with spinal cord injury - American Thoracic Society
Misuse of common antibiotic is creating resistant TB - JAMA and Archives Journals
Aspirin use after colorectal cancer diagnosis associated with improved survival - Johns Hopkins University Bloomberg School of Public Health
Guided care reduces cost of health care for older persons with chronic conditions - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
